Global

Pharmaceutical Sciences Experts

Luessen


Pharmaceutical Science
Promethra biosciences
Belgium

Biography

Henrik Luessen comes to Promethera as the Founder and Managing Director of Tytonis B.V., The Netherlands. At Promethera, Henrik serves as Chief Business Officer where he is responsible for identifying and executing strategic corporate development initiatives and licensing agreements. In the past, Henrik was involved in the foundation to trade sale of several life science firms such as Symbiotec GmbH, Nanomi BV and Activaero GmbH. He also served as Chief Business Officer at OctoPlus NV until its initial public offering in 2006. During his time at OctoPlus, Henrik commercially developed the company from a group of 12 employees with a core expertise in pharmaceutical development services of biopharmaceutical compounds to an organization of 140 people with two proprietary products in clinical development. During his career he has concluded around  250 IP-related, transactional and licensing deals. Henrik obtained his Ph.D. in Pharmaceutics and Biopharmaceutics from the Leiden/Amsterdam Center for Drug Research in 1996 and graduated at the University of Hamburg as Pharmacist in 1991. Henrik Luessen comes to Promethera as the Founder and Managing Director of Tytonis B.V., The Netherlands. At Promethera, Henrik serves as Chief Business Officer where he is responsible for identifying and executing strategic corporate development initiatives and licensing agreements. In the past, Henrik was involved in the foundation to trade sale of several life science firms such as Symbiotec GmbH, Nanomi BV and Activaero GmbH. He also served as Chief Business Officer at OctoPlus NV until its initial public offering in 2006. During his time at OctoPlus, Henrik commercially developed the company from a group of 12 employees with a core expertise in pharmaceutical development services of biopharmaceutical compounds to an organization of 140 people with two proprietary products in clinical development. During his career he has concluded around  250 IP-related, transactional and licensing deals. Henrik obtained his Ph.D. in Pharmaceutics and Biopharmaceutics from the Leiden/Amsterdam Center for Drug Research in 1996 and graduated at the University of Hamburg as Pharmacist in 1991.

Research Interest

Pharmaceutical Science 

Global Experts from Belgium

Global Experts in Subject

Share This Profile
Recent Expert Updates
  • Matthew L Stone
    Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.   Matthew
    Dr. Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone Matthew
    Dr. L Stone Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone
    Dr. L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr. Matthew L Stone
    Dr. Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  R Sameh
    Dr. R Sameh
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   R Ismail,
    Dr. R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Sameh R Ismail,
    Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   Sameh R Ismail,
    Dr. Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   William
    Dr. William
    pediatrics
    Maimonides Medical Center
    United States of America